商业化
免疫疗法
免疫系统
T细胞
体外
细胞培养
细胞
医学
免疫学
癌症研究
业务
生物
生物化学
遗传学
营销
作者
G. Økern,Angel Varela‐Rohena,Sandra Kuligowski,Brian Newsom,Tanja Aarvak
标识
DOI：10.1186/2051-1426-3-s2-p1
摘要
Meeting abstracts The manufacture of a majority of clinical T cell products for immunotherapy applications requires in vitro T cell culture and expansion. Commercialization of T cell manufacturing processes requires reagents that meet regulatory guidelines and ultimately help reduce manufacturing
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
学术文献互助
cdercder
GingerF
My_magnum_opus
Criminology34
Kao
然宝
DW
随风沙ZYX
Nole
heekkll
cocohan
XX
无极微光
skearthy
神勇映安
Juvenilesy
羽木风言
初景
aaaa
皖公网安备34019202002308
